Pompe-betegség: vizsgálatok itt: Egyesült Államok
13 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peoplePompe Disease Registry Protocol
- Where
- Ann Arbor, Aurora, Baltimore, Birmingham, Boston, Camden, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Coral Gables, Dallas, Decatur, Detroit, Dublin, Durham, Fairfax, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Helena, Hershey, Huntington, Indianapolis, Iowa City, Jacksonville, Kansas City, Las Vegas, Little Rock, Loma Linda, Los Angeles, Louisville, Milwaukee, Minneapolis, Morristown, Nashville, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Omaha, Orange, Paterson, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Rochester, Sacramento, Salt Lake City, San Bernardino, San Diego, San Francisco, Seattle, South Burlington, Springfield, Stanford, St Louis, Syracuse, Tacoma, Tampa, Tucson, Valhalla, Washington D.C.
- People
- 2000 worldwide
- Run by
- Genzyme, a Sanofi Company
See details and how to joinNCT00231400 - 1/2. fázisTaking peopleA Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
- Where
- Dallas, Durham, Irvine, New York, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Richmond
- Életkor
- 18 év to 65 év
- People
- 12
- Run by
- AskBio Inc
See details and how to joinNCT07282847 - 1. fázisTaking peopleA Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
- Where
- Durham, Fairfax, Irvine, St Louis
- Életkor
- 18 év to 75 év
- People
- 32 worldwide
- Run by
- Denali Therapeutics Inc.
See details and how to joinNCT07354724 · EU 2025-524082-25-00 - 2. fázisTaking peopleStudy of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
- Where
- Atlanta, Cincinnati, Durham, Fairfax, Gainesville, Irvine, Philadelphia, Pittsburgh, St Louis
- Életkor
- 18 év and over
- People
- 45 worldwide
- Run by
- Shionogi
See details and how to joinNCT07123155 - No phaseTaking peoplePompe Pregnancy Sub-Registry
- Where
- Atlanta, Dublin, Durham, Fairfax, Grand Rapids, Greenville, Indianapolis, Iowa City, Jacksonville, New York, Phoenix, Portland, St Louis
- People
- 20 worldwide
- Run by
- Genzyme, a Sanofi Company
See details and how to joinNCT00567073 - No phaseTaking peopleDetermination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- Where
- Durham
- People
- 400
- Run by
- Duke University
See details and how to joinNCT01665326 - No phaseTaking peopleRegistry of Patients Diagnosed With Lysosomal Storage Diseases
- Where
- San Francisco
- Életkor
- Up to 64 év
- People
- 250
- Run by
- University of California, San Francisco
See details and how to joinNCT05619900 - 1. fázisTaking peoplePEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
- Where
- San Francisco
- Életkor
- 18 év to 50 év
- People
- 10
- Run by
- University of California, San Francisco
See details and how to joinNCT04532047 - No phaseTaking peopleA Global Prospective Observational Registry of Patients With Pompe Disease
- Where
- Atlanta, Cincinnati, Durham, Fairfax, Indianapolis, Irvine, Jacksonville, Little Rock, New York, Philadelphia, Pittsburgh, Salt Lake City, St Louis
- People
- 500 worldwide
- Run by
- Amicus Therapeutics
See details and how to joinNCT06121011 - No phaseTaking peopleCognitive and Neurological Pathologies in Pompe Disease
- Where
- Durham
- Életkor
- 0 év to 18 év
- People
- 45
- Run by
- Duke University
See details and how to joinNCT04639336 - 3. fázisTaking peopleA Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18
- Where
- Atlanta, Cincinnati, Durham, Gainesville, Pittsburgh, Salt Lake City
- Életkor
- Up to 17 év
- People
- 36 worldwide
- Run by
- Amicus Therapeutics
See details and how to joinNCT04808505 · EU 2022-501095-25-01 - No phaseTaking peopleAvalglucosidase Alfa Pregnancy Study
- Where
- Bridgewater
- People
- 100
- Run by
- Sanofi
See details and how to joinNCT05734521 - No phaseTaking peopleLong-Term Development of Muscular Dystrophy Outcome Assessments
- Where
- Richmond
- Életkor
- 6 év to 50 év
- People
- 1000
- Run by
- Virginia Commonwealth University
See details and how to joinNCT05989620